ÂÜÀòÂÒÂ×

Russell Skibsted M.B.A. joined Alimera in January 2023 as Senior Vice President and Chief Financial Officer. Mr. Skibsted has nearly 30 years of experience in financial management, global business development, capital raises, investor relations, and operations in both public and private life sciences companies at all stages of development. Prior to joining Alimera, he served as Executive Vice President, CFO and Chief Business Officer at Rockwell Medical, a public company providing hemodialysis products. Previously, Mr. Skibsted served as CFO of BioTime, Inc. as well as with several of BioTime’s public and private subsidiaries, including Agex Therapeutics, OncoCyte Corporation and Asterias Biotherapeutics, Inc. Prior to BioTime, Mr. Skibsted served as CFO or Chief Business Officer for several public and private life science companies, including Aeolus Pharmaceuticals, Spectrum Pharmaceuticals and Hana Biosciences. He has also acted as a consulting CFO to various life science companies when he was the Managing Director of RSL Ventures and held roles as Portfolio Management Partner and CFO at Asset Management Company. Earlier in his career, he was Vice President for GE Capital Services Structured Finance Group. Mr. Skibsted holds a B.A. in Economics from Claremont McKenna College and an M.B.A. from the Stanford Graduate School of Business.